Skip to main content
OpenTrials
Completed

NCT Number: NCT04103099

Impact of HLNatural Immune Supplement on Colds

According to the Centers of Disease Control and Prevention (CDC) adults will have an average of 2-3 colds per year. Most colds will last approximately 7-10 days. The symptoms of colds could include cough, sore throat, runny nose, body aches, fevers, headaches and fatigue. A cold can affect your activity such as going to work, interrupting your sleep and your day to day activities. The test product contains all natural ingredients which have been combined into a powder to be taken in water at the sign of a cold.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Immune System Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hawthorne Effect, Inc.

Lafayette, California, 94549, United States

About this study

At the onset of a cold, mix 1 packet of the drink-mix product in 6-8 oz. of hot water. Drink the drink mix twice a day until symptoms are gone or 18 days, whichever comes first.

  • Complete the screening survey.
  • Sign the eConsent if approved.
  • Complete the baseline survey, demographic form, and Medication and Supplements form.
  • Receive test product and log into study portal and complete supplement receipt form. This will mark the start of your participation in this study.
  • Once you have a cold, complete the symptom survey.
  • Take test product.
  • Write down any adverse or ill effects any time after taking the test product.
  • Record if you took any additional medications or supplements daily during the course of your cold.
  • Note any final adverse events and complete the exit form.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult candidates in the general population who are in good health and are seeking herbal remedies to reduce the duration of their common cold symptoms when they should arise. Participants will be deemed to be in good health if they do not report any of the medical conditions asked about in the screening questionnaire.

Exclusion criteria

  • Age < 18 years old
  • Unwilling to try the test product during their first cold experience in the trial
  • Has any of the following medical conditions:
  • Chronic seasonal allergies
  • Allergy to any of the following ingredients: Echinacea, Ivy Extract, Camu Camu, Vitamin C, Ginger, Turmeric, Zinc or a known allergy to Guar Gum, Monk Fruit, Citric Acid, Natural Flavors.
  • Asthma
  • Current cold infection
  • Currently taking antimicrobial or antiviral medication
  • Alcohol consumption more than 7 drinks per week or more than 3 drinks per occasion
  • Routine recreational drug use
  • Chronic renal disease
  • Chronic liver disease
  • Known autoimmune or immunodeficiency disorders
  • Medically treated atopy or allergy
  • Pregnant or breastfeeding

Treatment and study plan

HLNatural Immune

Dietary Supplement

Vitamin C, Echinacea, Ivy Extract, Zinc, Ginger and Turmeric in a powder form mixed with water

Primary outcomes

  1. Outcome of freedom of cold symptoms while consuming HLNatural Supplement

    Time frame: At the onset of cold symptoms the symptoms will be measured for 18 days or sooner if the symptoms resolve.

    Cold symptoms will be measured until the symptoms resolve. Subjects must experience 2 of more symptoms which are: cough, hoarseness, muscle aches, nasal drainage, nasal congestion, scratchy throat, sore throat, sneezing, or an oral temperature of 37.7 C (99.9 F).

Secondary outcomes

  1. Outcome of the severity of cold symptoms while taking HLNatural Supplement

    Time frame: The diary will be completed daily during the duration of the the subject's cold.

    Subjects will rate the severity of the cold symptoms using Daily Symptom Survey of each possible symptom from 0-3 (3 is severe).

    • Comparison against the participant's normal behavior.
    • Net Promoter Score.
    • Adverse events will be summarized.
    • An additional data presentation will consist of results from both Treatment and Control in similar studies appearing in the literature. There will be no formal statistical comparison of results from this study and historical studies.

  2. Outcome of the duration of the cold symptoms while taking HLNatural Supplement

    Time frame: At the onset of cold symptoms until resolution of cold symptoms

    The length of time that the subject's cold will be recorded

  3. Required Behavior

    Time frame: During the duration of the cold symptoms

    Subjects will be asked to avoid over the counter cold-relief medication. However pain relievers and fever reducers are allowed

  4. Outcome all adverse events while taking HLNatural Supplement

    Time frame: Throughout the study

    All adverse events which are collected throughout the subjects participation will be recorded.

  5. Outcome of natural behavior of the participants while taking in the clinical trial

    Time frame: The subject will complete the screening, demographic and baseline surveys prior to the start of the product and the exit form at the end of the subject's cold symptoms

    All subjects will be asked to complete a screening, demographic and baseline questionnaire as well as and exit survey. The screening and baseline survey will be used to understand the subjects normal behavior with cold symptoms. The Exit study will rate the product to understand if the subject felt it helped with their cold symptoms

Sponsors and collaborators

Lead sponsor

Hawthorne Effect Inc.

Other

Collaborators

  • HLNatural, Inc.

Registry information

Official study title

Evaluation of the Impact of the HLNatural, Inc. Immune Support Product in Reducing the Length of Cold Symptoms in Adults Suffering From the Common Cold

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Sep 25, 2019
Registry last updated
Nov 15, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.